Related Experiment Video
Updated: May 17, 2026
10:03
Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy
Published on: August 2, 2024
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
Iain Brown1, Maria G Cascio, Dino Rotondo
1University of Aberdeen, School of Medicine and Dentistry, Cancer Medicine Research Group, Aberdeen, United Kingdom.
Progress in Lipid Research
|October 30, 2012
Summary
Cannabinoids and endocannabinoids show potential in cancer prevention and therapy by inducing apoptosis and inhibiting tumor growth. Further research is needed to explore their synergistic effects with chemotherapy.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Cannabinoids and endocannabinoids interact with cannabinoid receptors (CB(½), TRPV1) and other signaling pathways.
- These compounds exhibit anti-inflammatory, anti-proliferative, anti-invasive, anti-metastatic, and pro-apoptotic effects in various cancers.
- Non-receptor-mediated signaling pathways also contribute to their diverse biological activities.
Purpose of the Study:
- To review the multifaceted roles of cannabinoids and endocannabinoids in cancer.
- To explore their signaling mechanisms, including receptor-mediated and non-receptor-mediated pathways.
- To investigate the potential of omega-3 fatty acids (EPA, DHA) in forming bioactive endocannabinoids for cancer therapy.
Main Methods:
- Review of in vitro and in vivo studies on cannabinoid and endocannabinoid effects in cancer models.
- Analysis of signaling pathways involved, such as MAPK, PI3K/AKT, and NF-κB.
- Examination of evidence for EPA and DHA forming endocannabinoids and their bioactivity.
Main Results:
- Cannabinoids-endocannabinoids induce cell cycle arrest, autophagy, apoptosis, and tumor inhibition via multiple signaling cascades.
- Paradoxical pro-proliferative and anti-apoptotic effects observed in some cancers due to receptor expression and concentration differences.
- EPA and DHA can form endocannabinoids with receptor-mediated and non-receptor-mediated anti-cancer activities, augmenting chemotherapy.
Conclusions:
- Cannabinoids-endocannabinoids, including those derived from omega-3 fatty acids, demonstrate significant anti-cancer potential.
- Their ability to modulate various signaling pathways and synergize with chemotherapeutic agents warrants further investigation.
- Urgent clinical studies are required to establish their therapeutic efficacy and optimal use in cancer treatment.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
14:25Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
Published on: September 21, 2019
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.